A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Patients With Motor Fluctuations A Study to Evaluate the Safety and Efficacy of IPX203in Parkinson's Disease Patients With Motor Fluc ...
A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203 With Immediate-Release Carbidopa-Levodopa in Parkinson's Disease Patients With Motor Fluctuations A Randomized Controlled Study to Compare the Safety and Efficacy of IPX203With Immediate-Release Car ...
Parkinson's Disease (Disorder)
Drug: IR CD-LD;Drug: IPX203ERCD-LD;Other: IPX203 placebo;Other: IR CD-LD placebo
Impax Laboratories, LLC
NULL
Completed
40 Years
N/A
All
631
Phase 3
United States;Czechia;France;Germany;Italy;Poland;Spain;United Kingdom
A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease A Study to Assess the PK and Pharmacodynamics of IPX203in Subjects With Advanced Parkinson's Disease ...
A Randomized, Multiple Dose Study to Assess the Pharmacokinetics and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease A Randomized, Multiple Dose Study to Assess the Pharmacokinetics and Pharmacodynamics of IPX203in Su ...